MarketCapTrends
CTXR
Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ · Healthcare

Citius Pharmaceuticals, Inc. Total Liabilities 2011–2022

Citius Pharmaceuticals, Inc. annual/quarterly total liabilities history from 2011 to 2022. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Citius Pharmaceuticals, Inc. total liabilities for the quarter ending September 30, 2022 were 10.6M, a 9.61% increase year-over-year.
  • Citius Pharmaceuticals, Inc. total liabilities for 2022 were 10.6M, a 9.61% increase from 2021.
  • Citius Pharmaceuticals, Inc. total liabilities for 2021 were 9.6M, a 4.52% decrease from 2020.
  • Citius Pharmaceuticals, Inc. total liabilities for 2020 were 10.1M, a 5.31% increase from 2019.
  • Citius Pharmaceuticals, Inc. total liabilities for 2019 were 9.6M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Citius Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $)
2022$11
2021$10
2020$10
2019$10
2018$0
2017$2
2013$0
2012$0
2011$0
Citius Pharmaceuticals, Inc. Quarterly Total Liabilities (Millions of US $)
2022-09-30$11
2021-09-30$10
2020-09-30$10
2019-09-30$10
2018-09-30$0
2017-09-30$2
2013-09-30$0
2012-09-30$0
2011-09-30$0

Citius Pharmaceuticals, Inc. Total Liabilities — FAQ

Citius Pharmaceuticals, Inc. (CTXR) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CTXR's total liabilities history?

The chart and table above show Citius Pharmaceuticals, Inc.'s total liabilities by year and by quarter, including the growth rate.